Hassane M. Zarour, MD, discusses the addition of antibiotics to immunotherapy treatment in patients with melanoma.
Hassane M. Zarour, MD, professor of medicine and immunology at the University of Pittsburgh, discusses the addition of antibiotics to immunotherapy treatment in patients with melanoma.
According to Zarour, clinicians should think twice about whether the patient needs antibiotics, because they could be deleterious to a specific therapy.
Management of Immune-Related Toxicities in Melanoma Has Improved Over Time
April 24th 2024During a Case-Based Roundtable® event, Evan J. Lipson, MD, discussed with participants how their experience with immunotherapy toxicities has changed over time in the first article of a 2-part series.
Read More